ORTHOFIX MEDICAL INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • November 7th, 2024 • Orthofix Medical Inc. • Surgical & medical instruments & apparatus
Contract Type FiledNovember 7th, 2024 Company IndustryThis AGREEMENT (the “Agreement”) is made and entered into as of June 10, 2024 (the “Effective Date”), by and between Orthofix Medical Inc., a Delaware corporation (together with its direct and indirect subsidiaries, the “Company”), and Max Reinhardt (the “Executive”).
ORTHOFIX MEDICAL INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • November 7th, 2024 • Orthofix Medical Inc. • Surgical & medical instruments & apparatus
Contract Type FiledNovember 7th, 2024 Company IndustryThis AGREEMENT (the “Agreement”) is made and entered into as of August 15, 2024 (the “Effective Date”), by and between Orthofix Medical Inc., a Delaware corporation (together with its direct and indirect subsidiaries, the “Company”), and Patrick Fisher (the “Executive”).
ORTHOFIX MEDICAL INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • May 7th, 2024 • Orthofix Medical Inc. • Surgical & medical instruments & apparatus
Contract Type FiledMay 7th, 2024 Company IndustryThis AGREEMENT (the “Agreement”) is made and entered into as of March 15, 2024 (the “Effective Date”), by and between Orthofix Medical Inc., a Delaware corporation (together with its direct and indirect subsidiaries, the “Company”), and Lucas Vitale (the “Executive”).
ORTHOFIX MEDICAL INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • May 7th, 2024 • Orthofix Medical Inc. • Surgical & medical instruments & apparatus
Contract Type FiledMay 7th, 2024 Company IndustryThis AGREEMENT (the “Agreement”) is made and entered into as of April 15, 2024 (the “Effective Date”), by and between Orthofix Medical Inc., a Delaware corporation (together with its direct and indirect subsidiaries, the “Company”), and Andres Cedron (the “Executive”).
ORTHOFIX MEDICAL INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • January 17th, 2024 • Orthofix Medical Inc. • Surgical & medical instruments & apparatus
Contract Type FiledJanuary 17th, 2024 Company IndustryThis AGREEMENT (the “Agreement”) is made and entered into as of January 15, 2024 (the “Effective Date”), by and between Orthofix Medical Inc., a Delaware corporation (together with its direct and indirect subsidiaries, the “Company”), and Julie Andrews (the “Executive”).
ORTHOFIX MEDICAL INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • January 9th, 2024 • Orthofix Medical Inc. • Surgical & medical instruments & apparatus • California
Contract Type FiledJanuary 9th, 2024 Company Industry JurisdictionThis AGREEMENT (the “Agreement”) is made and entered into as of January 8, 2024 (the “Effective Date”), by and between Orthofix Medical Inc., a Delaware corporation (together with its direct and indirect subsidiaries, the “Company”), and Massimo Calafiore (the “Executive”).
ORTHOFIX MEDICAL INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • November 8th, 2023 • Orthofix Medical Inc. • Surgical & medical instruments & apparatus
Contract Type FiledNovember 8th, 2023 Company IndustryThis AGREEMENT (the “Agreement”) is made and entered into as of June 21, 2023 (the “Effective Date”), by and between Orthofix Medical Inc., a Delaware corporation (together with its direct and indirect subsidiaries, the “Company”), and Puja Leekha (the “Executive”).
ORTHOFIX MEDICAL INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • June 21st, 2023 • Orthofix Medical Inc. • Surgical & medical instruments & apparatus
Contract Type FiledJune 21st, 2023 Company IndustryThis AGREEMENT (the “Agreement”) is made and entered into as of June 19, 2023 (the “Effective Date”), by and between Orthofix Medical Inc., a Delaware corporation (together with its direct and indirect subsidiaries, the “Company”), and Kimberley A. Elting (the “Executive”).
ORTHOFIX MEDICAL INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • June 21st, 2023 • Orthofix Medical Inc. • Surgical & medical instruments & apparatus
Contract Type FiledJune 21st, 2023 Company IndustryThis AGREEMENT (the “Agreement”) is made and entered into as of June 19, 2023 (the “Effective Date”), by and between Orthofix Medical Inc., a Delaware corporation (together with its direct and indirect subsidiaries, the “Company”), and Kevin J. Kenny (the “Executive”).
ORTHOFIX MEDICAL INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • June 21st, 2023 • Orthofix Medical Inc. • Surgical & medical instruments & apparatus
Contract Type FiledJune 21st, 2023 Company IndustryThis AGREEMENT (the “Agreement”) is made and entered into as of June 19, 2023 (the “Effective Date”), by and between Orthofix Medical Inc., a Delaware corporation (together with its direct and indirect subsidiaries, the “Company”), and Patrick L. Keran (the “Executive”).
ORTHOFIX MEDICAL INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • June 21st, 2023 • Orthofix Medical Inc. • Surgical & medical instruments & apparatus
Contract Type FiledJune 21st, 2023 Company IndustryThis AGREEMENT (the “Agreement”) is made and entered into as of June 19, 2023 (the “Effective Date”), by and between Orthofix Medical Inc., a Delaware corporation (together with its direct and indirect subsidiaries, the “Company”), and John Bostjancic (the “Executive”).
ORTHOFIX MEDICAL INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • June 21st, 2023 • Orthofix Medical Inc. • Surgical & medical instruments & apparatus
Contract Type FiledJune 21st, 2023 Company IndustryThis AGREEMENT (the “Agreement”) is made and entered into as of June 19, 2023 (the “Effective Date”), by and between Orthofix Medical Inc., a Delaware corporation (together with its direct and indirect subsidiaries, the “Company”), and Keith C. Valentine (the “Executive”).